Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 144

1.

Prevention and treatment of alloantibody-mediated kidney transplant rejection.

Bartel G, Schwaiger E, Böhmig GA.

Transpl Int. 2011 Dec;24(12):1142-55. doi: 10.1111/j.1432-2277.2011.01309.x. Epub 2011 Aug 10. Review.

PMID:
21831227
[PubMed - indexed for MEDLINE]
2.

Successful kidney transplantation after desensitization using plasmapheresis, low-dose intravenous immunoglobulin, and rituximab in highly sensitized patients: a single-center experience.

Jin MK, Cho JH, Kwon O, Hong KD, Choi JY, Yoon SH, Park SH, Kim YL, Kim CD.

Transplant Proc. 2012 Jan;44(1):200-3. doi: 10.1016/j.transproceed.2011.11.040.

PMID:
22310614
[PubMed - indexed for MEDLINE]
3.

The role of therapeutic apheresis in the treatment of acute antibody-mediated kidney rejection.

Ahmed T, Senzel L.

J Clin Apher. 2012;27(4):173-7. doi: 10.1002/jca.21211. Epub 2012 Mar 13. Review.

PMID:
22411078
[PubMed - indexed for MEDLINE]
4.

Kidney transplant in highly sensitized patients after desensitization with plasmapheresis and low-dose intravenous immunoglobulin.

Yuan XP, Wang CX, Gao W, Fu Q, He XS.

Exp Clin Transplant. 2010 Jun;8(2):130-5.

PMID:
20565369
[PubMed - indexed for MEDLINE]
Free Article
5.

Sensitized renal transplant recipients: current protocols and future directions.

Gloor J, Stegall MD.

Nat Rev Nephrol. 2010 May;6(5):297-306. doi: 10.1038/nrneph.2010.34. Epub 2010 Mar 16. Review.

PMID:
20234355
[PubMed - indexed for MEDLINE]
6.

Living donor kidney transplantation in patients with donor-specific HLA antibodies enabled by anti-CD20 therapy and peritransplant apheresis.

Klein K, Süsal C, Schäfer SM, Becker LE, Beimler J, Schwenger V, Zeier M, Schemmer P, Macher-Goeppinger S, Scherer S, Opelz G, Morath C.

Atheroscler Suppl. 2013 Jan;14(1):199-202. doi: 10.1016/j.atherosclerosissup.2012.10.030.

PMID:
23357165
[PubMed - indexed for MEDLINE]
7.

The acceptable reactive crossmatch (ARC), post-transplant monitoring, and their impact on kidney transplantation: a single center experience.

Leone JP, Bowers V, Baliga R, Sanders C, LeFor W, Becker D, Thompson D, Resto-Ruiz S, Lopez-Cepero M.

Clin Transpl. 2011:373-9.

PMID:
22755434
[PubMed - indexed for MEDLINE]
8.

Transplantation of the broadly sensitized patient: what are the options?

Böhmig GA, Wahrmann M, Bartel G.

Curr Opin Organ Transplant. 2011 Dec;16(6):588-93. doi: 10.1097/MOT.0b013e32834c23ba. Review.

PMID:
21971512
[PubMed - indexed for MEDLINE]
9.

Recent developments in desensitization of crossmatch-positive kidney transplant recipients.

Morath C, Opelz G, Zeier M, Süsal C.

Transplant Proc. 2012 Jul-Aug;44(6):1648-51. doi: 10.1016/j.transproceed.2012.04.006. Review.

PMID:
22841236
[PubMed - indexed for MEDLINE]
10.

Antibody-mediated rejection: treatment alternatives and outcomes.

Singh N, Pirsch J, Samaniego M.

Transplant Rev (Orlando). 2009 Jan;23(1):34-46. doi: 10.1016/j.trre.2008.08.004. Review.

PMID:
19027615
[PubMed - indexed for MEDLINE]
11.

Peritransplant immunoadsorption for positive crossmatch deceased donor kidney transplantation.

Bartel G, Wahrmann M, Regele H, Kikić Z, Fischer G, Druml W, Mühlbacher F, Böhmig GA.

Am J Transplant. 2010 Sep;10(9):2033-42. doi: 10.1111/j.1600-6143.2010.03226.x.

PMID:
20883537
[PubMed - indexed for MEDLINE]
Free Article
12.

Characterization of rejection episodes in patients following positive crossmatch and ABO-incompatible live donor renal transplantation.

Kayler LK, Farber JL, Colombe B, LaCava D, Friedewald JJ, Ratner LE.

Transpl Int. 2006 Feb;19(2):128-39.

PMID:
16441362
[PubMed - indexed for MEDLINE]
13.
14.

Long-term outcomes of kidney transplantation across a positive complement-dependent cytotoxicity crossmatch.

Riella LV, Safa K, Yagan J, Lee B, Azzi J, Najafian N, Abdi R, Milford E, Mah H, Gabardi S, Malek S, Tullius SG, Magee C, Chandraker A.

Transplantation. 2014 Jun 27;97(12):1247-52. doi: 10.1097/01.TP.0000442782.98131.7c.

PMID:
24854670
[PubMed - indexed for MEDLINE]
15.

Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.

Mai ML, Ahsan N, Wadei HM, Genco PV, Geiger XJ, Willingham DL, Taner CB, Hewitt WR, Grewal HP, Nguyen JH, Hughes CB, Gonwa TA.

Transplantation. 2009 Jan 27;87(2):227-32. doi: 10.1097/TP.0b013e31818c962b.

PMID:
19155977
[PubMed - indexed for MEDLINE]
16.

[Role of antibodies in kidney transplant].

Ruffoni E, Seveso M, Marson P, Tison T, Cozzi E.

G Ital Nefrol. 2012 Jan-Feb;29 Suppl 54:S54-60. Italian.

PMID:
22388831
[PubMed - indexed for MEDLINE]
17.

Proteasome inhibitor-based therapy for antibody-mediated rejection.

Walsh RC, Alloway RR, Girnita AL, Woodle ES.

Kidney Int. 2012 Jun;81(11):1067-74. doi: 10.1038/ki.2011.502. Epub 2012 Feb 15. Review.

PMID:
22336990
[PubMed - indexed for MEDLINE]
18.

Desensitization and crossmatch conversion in deceased donor kidney transplantation.

Bartel G, Böhmig GA.

Minerva Urol Nefrol. 2011 Mar;63(1):21-34. Review.

PMID:
21336243
[PubMed - indexed for MEDLINE]
19.

Persistence of low levels of alloantibody after desensitization in crossmatch-positive living-donor kidney transplantation.

Gloor JM, DeGoey S, Ploeger N, Gebel H, Bray R, Moore SB, Dean PG, Stegall MD.

Transplantation. 2004 Jul 27;78(2):221-7.

PMID:
15280682
[PubMed - indexed for MEDLINE]
20.

Immunoadsorption with protein A in humoral rejection of kidney transplants.

Pretagostini R, Berloco P, Poli L, Cinti P, Di Nicuolo A, De Simone P, Colonnello M, Salerno A, Alfani D, Cortesini R.

ASAIO J. 1996 Sep-Oct;42(5):M645-8.

PMID:
8944960
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk